方盛制药 - Financials

方盛制药 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
+Revenue	1.8B	1.6B	1.8B	1.6B	1.3B	1.1B	1.1B	721.0M	534.0M	469.0M	416.0M	400.0M	332.0M	263.0M
Revenue Growth %	9.1%	-9.1%	14.4%	22.5%	16.9%	4.1%	45.8%	35.0%	13.9%	12.7%	4.0%	20.5%	26.2%	--
Total Revenue	1.8B	1.6B	1.8B	1.6B	1.3B	1.1B	1.1B	721.0M	534.0M	469.0M	416.0M	400.0M	332.0M	263.0M
Cost Of Revenue	500.0M	520.0M	586.0M	563.0M	464.0M	300.0M	273.0M	288.0M	271.0M	206.0M	218.0M	235.0M	184.0M	153.0M
+Gross Profit	1.3B	1.1B	1.2B	1.0B	815.0M	794.0M	778.0M	433.0M	263.0M	263.0M	198.0M	165.0M	148.0M	110.0M
Gross Margin %	71.9%	68.1%	67.3%	64.1%	63.7%	72.6%	74.0%	60.1%	49.3%	56.1%	47.6%	41.2%	44.6%	41.8%
Total Operating Cost	1.6B	1.5B	1.7B	1.5B	1.2B	1.0B	957.0M	644.0M	449.0M	368.0M	321.0M	315.0M	257.0M	203.0M
Selling Expenses	703.0M	658.0M	755.0M	633.0M	483.0M	540.0M	534.0M	223.0M	79.1M	69.4M	35.4M	27.1M	26.4M	14.1M
Admin Expenses	146.0M	149.0M	188.0M	169.0M	157.0M	103.0M	82.8M	82.9M	95.8M	90.7M	64.3M	49.5M	44.0M	34.3M
Rd Expenses	139.0M	108.0M	70.4M	51.4M	53.6M	41.2M	42.3M	29.4M	--	--	--	--	--	--
Finance Expenses	12.5M	10.8M	19.9M	17.7M	13.7M	4.0M	-2.9M	-642,400	-6.6M	-5.4M	-1.8M	-568,500	-868,000	-600,000
+Operating Income	285.0M	196.0M	332.0M	99.7M	72.4M	96.4M	92.1M	80.2M	84.2M	109.0M	95.0M	85.0M	75.8M	59.4M
Operating Margin %	16.0%	12.0%	18.5%	6.4%	5.7%	8.8%	8.8%	11.1%	15.8%	23.2%	22.8%	21.2%	22.8%	22.6%
Non Operating Income	1.3M	8.6M	498,900	485,400	1.5M	389,700	632,800	633,600	4.8M	8.7M	6.1M	3.9M	2.7M	3.0M
Non Operating Expenses	635,500	1.7M	6.0M	9.4M	4.9M	2.3M	529,100	477,600	389,000	2.9M	236,600	55,800	152,700	189,100
Investment Income	38.6M	-3.9M	166.0M	-9.6M	-18.7M	11.2M	-12.9M	-4.5M	-933,900	8.0M	--	--	--	--
Fair Value Change Income	-21,200	49,100	-63,400	126,800	15,300	-41,200	--	--	--	--	--	--	--	--
Asset Disposal Income	746,400	11.5M	-903,500	-71,300	2,000	286,700	-120,200	42,400	196,100	--	--	--	--	--
Asset Impairment Loss	20.6M	2.3M	1.2M	11.9M	5.6M	4.5M	5.8M	8.5M	1.7M	1.1M	1.4M	1.2M	322,900	-75,300
Other Income	26.2M	39.5M	46.0M	17.2M	19.9M	13.1M	10.9M	7.4M	--	--	--	--	--	--
Income Before Tax	286.0M	203.0M	327.0M	90.8M	69.0M	94.5M	92.2M	80.4M	88.6M	115.0M	101.0M	88.8M	78.3M	62.1M
Income Tax	36.1M	23.7M	49.9M	20.9M	15.2M	15.5M	12.4M	15.7M	15.2M	17.8M	15.0M	13.2M	11.3M	10.5M
+Net Income	250.0M	180.0M	277.0M	69.9M	53.8M	79.0M	79.8M	64.6M	73.4M	96.9M	85.9M	75.6M	67.0M	51.6M
Net Margin %	14.1%	11.0%	15.5%	4.5%	4.2%	7.2%	7.6%	9.0%	13.8%	20.7%	20.6%	18.9%	20.2%	19.6%
Net Income Attributable	255.0M	187.0M	286.0M	70.0M	63.8M	78.9M	73.0M	59.7M	69.8M	90.7M	81.0M	73.4M	66.1M	51.9M
Minority Interest	-5.4M	-7.2M	-9.1M	-119,400	-10.0M	63,300	6.8M	4.9M	3.7M	6.2M	4.9M	2.2M	906,200	-270,400
Eps Basic	0.59	0.43	0.66	0.16	0.15	0.19	0.17	0.14	0.16	0.21	0.96	0.90	0.81	0.63
Eps Diluted	0.58	0.42	0.66	0.16	0.15	0.18	0.17	0.14	0.16	0.21	0.96	0.90	0.81	0.63

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash And Equivalents	308.0M	209.0M	400.0M	259.0M	319.0M	156.0M	318.0M	141.0M	363.0M	533.0M	497.0M	127.0M	49.7M	80.2M
Trading Financial Assets	--	20.3M	40.3M	15.4M	296,200	287,500	--	--	--	--	--	--	--	--
Accounts Receivable	250.0M	210.0M	178.0M	243.0M	183.0M	160.0M	101.0M	50.1M	20.2M	6.5M	3.3M	2.3M	3.0M	2.6M
Notes Receivable	--	--	--	--	--	--	15.3M	18.9M	21.2M	29.7M	27.6M	25.4M	13.0M	16.8M
Notes And Accounts Receivable	250.0M	210.0M	178.0M	243.0M	183.0M	160.0M	116.0M	69.0M	41.5M	36.2M	30.9M	27.7M	15.9M	19.4M
Prepayments	63.1M	105.0M	66.6M	27.8M	24.2M	21.4M	19.7M	31.3M	18.8M	35.6M	3.9M	4.1M	37.2M	31.4M
Inventory	376.0M	328.0M	303.0M	257.0M	210.0M	207.0M	193.0M	172.0M	105.0M	85.9M	86.6M	76.7M	74.8M	39.7M
Total Current Assets	1.1B	921.0M	1.2B	867.0M	796.0M	645.0M	699.0M	513.0M	552.0M	698.0M	621.0M	237.0M	180.0M	173.0M
Long Term Equity Investment	239.0M	258.0M	252.0M	193.0M	139.0M	120.0M	140.0M	124.0M	115.0M	--	--	--	--	--
Fixed Assets	--	813.0M	650.0M	572.0M	535.0M	504.0M	407.0M	370.0M	268.0M	234.0M	147.0M	135.0M	119.0M	44.9M
Fixed Assets Total	829.0M	813.0M	650.0M	572.0M	535.0M	504.0M	407.0M	370.0M	268.0M	234.0M	147.0M	135.0M	119.0M	44.9M
Construction In Progress	--	218.0M	190.0M	202.0M	122.0M	97.2M	44.5M	52.1M	93.9M	9.8M	48.7M	909,700	7.3M	48.3M
Construction In Progress Total	262.0M	218.0M	190.0M	202.0M	122.0M	97.2M	44.5M	52.1M	93.9M	9.8M	48.7M	909,700	7.3M	48.3M
Intangible Assets	282.0M	268.0M	274.0M	250.0M	227.0M	243.0M	160.0M	155.0M	132.0M	111.0M	84.8M	87.7M	59.3M	61.5M
Long Term Deferred Expenses	13.8M	18.1M	8.1M	41.1M	43.0M	36.3M	4.2M	1.5M	656,900	523,200	--	--	--	--
Total Non Current Assets	2.1B	2.2B	1.7B	1.8B	1.4B	1.4B	943.0M	860.0M	719.0M	369.0M	307.0M	230.0M	196.0M	155.0M
Total Assets	3.3B	3.1B	2.9B	2.7B	2.2B	2.0B	1.6B	1.4B	1.3B	1.1B	928.0M	466.0M	376.0M	327.0M
Short Term Borrowings	531.0M	309.0M	210.0M	444.0M	408.0M	276.0M	180.0M	66.3M	65.2M	--	--	--	--	--
Accounts Payable	182.0M	114.0M	85.5M	107.0M	85.6M	75.8M	48.3M	43.3M	24.1M	25.2M	13.2M	29.4M	18.5M	26.5M
Advance Receipts	8.6M	2.8M	18,300	18,300	54,500	24.4M	24.8M	25.2M	18.7M	15.7M	21.4M	11.2M	8.1M	7.5M
Contract Liabilities	27.7M	36.2M	87.4M	35.1M	26.2M	--	--	--	--	--	--	--	--	--
Total Current Liabilities	1.3B	1.2B	1.0B	1.3B	877.0M	689.0M	470.0M	282.0M	236.0M	94.4M	54.2M	56.2M	37.8M	52.6M
Long Term Borrowings	147.0M	153.0M	298.0M	27.8M	25.3M	30.3M	--	--	--	--	--	--	--	--
Total Non Current Liabilities	233.0M	244.0M	415.0M	145.0M	101.0M	103.0M	60.0M	53.1M	55.3M	40.5M	32.3M	23.2M	19.2M	16.2M
Total Liabilities	1.5B	1.5B	1.4B	1.4B	977.0M	793.0M	530.0M	335.0M	291.0M	135.0M	86.5M	79.5M	57.0M	68.9M
Paid In Capital	439.0M	440.0M	439.0M	429.0M	429.0M	434.0M	429.0M	431.0M	433.0M	142.0M	109.0M	81.8M	81.8M	81.8M
Capital Reserve	190.0M	186.0M	164.0M	132.0M	132.0M	142.0M	140.0M	155.0M	169.0M	397.0M	397.0M	54.7M	57.1M	57.1M
Surplus Reserve	158.0M	134.0M	112.0M	88.6M	78.0M	69.6M	60.5M	53.5M	47.5M	40.5M	31.6M	23.8M	16.7M	10.1M
Retained Earnings	837.0M	716.0M	705.0M	546.0M	512.0M	508.0M	452.0M	390.0M	341.0M	306.0M	270.0M	197.0M	138.0M	86.1M
Minority Equity	112.0M	131.0M	118.0M	108.0M	114.0M	75.5M	58.9M	52.9M	51.3M	46.3M	34.1M	29.7M	25.1M	23.4M
Equity Attributable	1.6B	1.5B	1.4B	1.2B	1.2B	1.1B	1.1B	985.0M	928.0M	885.0M	808.0M	357.0M	294.0M	235.0M
Total Equity	1.7B	1.6B	1.5B	1.3B	1.3B	1.2B	1.1B	1.0B	980.0M	932.0M	842.0M	387.0M	319.0M	258.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash From Sales	1.8B	1.6B	1.9B	1.6B	1.3B	1.1B	1.1B	728.0M	549.0M	465.0M	425.0M	402.0M	328.0M	264.0M
Tax Refunds Received	6.8M	35.9M	13.2M	33,900	--	--	--	--	--	--	--	--	--	--
Total Operating Cash Inflow	1.8B	1.7B	2.0B	1.7B	1.4B	1.2B	1.1B	740.0M	580.0M	479.0M	440.0M	406.0M	333.0M	282.0M
Cash Paid For Goods	442.0M	523.0M	432.0M	434.0M	294.0M	210.0M	204.0M	320.0M	236.0M	158.0M	201.0M	165.0M	191.0M	132.0M
Cash Paid To Employees	278.0M	278.0M	341.0M	337.0M	282.0M	151.0M	97.9M	96.4M	83.3M	65.5M	50.6M	41.5M	34.7M	25.3M
Taxes Paid	207.0M	226.0M	191.0M	171.0M	83.2M	163.0M	143.0M	93.6M	63.6M	68.9M	53.8M	43.5M	44.3M	35.0M
Total Operating Cash Outflow	1.6B	1.7B	1.7B	1.5B	1.1B	1.0B	945.0M	723.0M	461.0M	389.0M	346.0M	283.0M	309.0M	217.0M
Operating Cash Flow	195.0M	87.5M	302.0M	186.0M	237.0M	163.0M	176.0M	17.0M	119.0M	90.6M	94.2M	123.0M	24.2M	65.2M
Total Investing Cash Inflow	214.0M	174.0M	280.0M	358.0M	146.0M	292.0M	56.4M	8.9M	18.3M	212.0M	3.8M	16.2M	2.5M	16.7M
Total Investing Cash Outflow	172.0M	371.0M	582.0M	588.0M	320.0M	640.0M	115.0M	224.0M	387.0M	271.0M	97.4M	54.6M	47.8M	50.7M
Investing Cash Flow	41.0M	-197.0M	-301.0M	-230.0M	-174.0M	-348.0M	-58.8M	-215.0M	-369.0M	-59.1M	-93.6M	-38.4M	-45.3M	-33.9M
Cash From Borrowings	907.0M	499.0M	735.0M	530.0M	459.0M	306.0M	180.0M	131.0M	65.2M	--	--	--	--	--
Dividends And Interest Paid	137.0M	180.0M	133.0M	55.0M	70.9M	44.4M	9.6M	10.3M	32.4M	16.1M	467,100	7.6M	7.5M	6.6M
Debt Repayments	884.0M	381.0M	687.0M	490.0M	326.0M	180.0M	66.3M	130.0M	--	--	--	--	--	--
Total Financing Cash Inflow	911.0M	522.0M	983.0M	543.0M	515.0M	346.0M	180.0M	133.0M	133.0M	--	378.0M	--	816,900	1.2M
Total Financing Cash Outflow	1.0B	613.0M	856.0M	557.0M	414.0M	327.0M	119.0M	157.0M	34.4M	16.1M	7.5M	7.6M	10.2M	9.0M
Financing Cash Flow	-122.0M	-91.5M	127.0M	-14.1M	101.0M	19.5M	60.5M	-23.9M	98.4M	-16.1M	370.0M	-7.6M	-9.4M	-7.8M
Net Change In Cash	114.0M	-201.0M	127.0M	-58.5M	164.0M	-165.0M	178.0M	-222.0M	-152.0M	15.4M	371.0M	76.9M	-30.5M	23.4M
Ending Cash Balance	296.0M	182.0M	383.0M	257.0M	315.0M	152.0M	317.0M	139.0M	361.0M	513.0M	497.0M	127.0M	49.7M	80.2M
Capex	94.8M	219.0M	171.0M	185.0M	168.0M	199.0M	74.9M	133.0M	167.0M	70.7M	97.4M	54.6M	47.8M	50.7M